Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5900184 | Diabetes Research and Clinical Practice | 2012 | 6 Pages |
Abstract
Plasma ADMA levels are increased in subjects with NAFLD. This increase seems to be independent from traditional cardiovascular risk factors, insulin resistance and liver histology. Circulating ADMA may be an earlier marker of vascular damage with respect to CIMT in subjects with NAFLD.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Teoman Dogru, Halil Genc, Serkan Tapan, Cemal Nuri Ercin, Fatih Ors, Fatih Aslan, Muammer Kara, Erdim Sertoglu, Sait Bagci, İsmail Kurt, Alper Sonmez,